In fact, the release of sEV PD-1 was suppressed in a cancer cell model in which the RAB27A and nSMase2 genes, which are related to sEV secretion, were deleted, thereby increasing the response to ICBT through the activation of immune cells [14]. Here, SMPD3 is linked to cancer.